RemeGen Co Company Top Insiders
| REGMF Stock | USD 9.93 0.00 0.00% |
RemeGen Co employs about 2.1 K people. The company is managed by 9 executives with a total tenure of roughly 4949 years, averaging almost 549.0 years of service per executive, having 235.67 employees per reported executive. Examination of RemeGen Co's management performance can provide insight into the company performance.
| Daotian Fu Insider President |
| Jianmin Fang Insider CEO, CoFounder |
RemeGen |
RemeGen Co Management Team Effectiveness
RemeGen Co's management efficiency ratios could be used to measure how well RemeGen Co manages its routine affairs as well as how well it operates its assets and liabilities.RemeGen Co Workforce Comparison
RemeGen Co is rated third in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 257,849. RemeGen Co maintains roughly 2,121 in number of employees contributing less than 1% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. RemeGen Co Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. RemeGen Co Price Series Summation is a cross summation of RemeGen Co price series and its benchmark/peer.
RemeGen Co Notable Stakeholders
A RemeGen Co stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as RemeGen Co often face trade-offs trying to please all of them. RemeGen Co's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting RemeGen Co's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Daotian Fu | President | Profile | |
| Jianmin Fang | CEO, CoFounder | Profile | |
| Jian Lin | Ex Director | Profile | |
| Qingkai Wen | Board Sec | Profile | |
| Marie Zhu | Chief Officer | Profile | |
| Kaisheng Huang | Chief Officer | Profile | |
| ACS ACIS | Joint Sec | Profile | |
| Ruyi MD | Head Officer | Profile | |
| Jason Li | CFO Sec | Profile |
About RemeGen Co Management Performance
The success or failure of an entity such as RemeGen Co often depends on how effective the management is. RemeGen Co management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RemeGen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RemeGen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company was incorporated in 2008 and is headquartered in Yantai, the Peoples Republic of China. Remegen is traded on OTC Exchange in the United States.
RemeGen Co Workforce Analysis
Traditionally, organizations such as RemeGen Co use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare RemeGen Co within its industry.RemeGen Co Manpower Efficiency
Return on RemeGen Co Manpower
| Revenue Per Employee | 671.3K | |
| Revenue Per Executive | 158.2M | |
| Net Income Per Employee | 130.2K | |
| Net Income Per Executive | 30.7M |
Complementary Tools for RemeGen Pink Sheet analysis
When running RemeGen Co's price analysis, check to measure RemeGen Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RemeGen Co is operating at the current time. Most of RemeGen Co's value examination focuses on studying past and present price action to predict the probability of RemeGen Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RemeGen Co's price. Additionally, you may evaluate how the addition of RemeGen Co to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |